Becton, Dickinson and Company Share Price Nyse
Equities
BDXA
US0758872081
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-5.43% | -9.50% |
Sales 2024 * | 20.25B 1,581B | Sales 2025 * | 21.47B 1,676B | Capitalization | 66.14B 5,162B |
---|---|---|---|---|---|
Net income 2024 * | 2.09B 163B | Net income 2025 * | 2.48B 193B | EV / Sales 2024 * | 3.91 x |
Net Debt 2024 * | 13.13B 1,025B | Net Debt 2025 * | 10.8B 843B | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
28.5
x | Employees | - |
Yield 2024 * |
1.64% | Yield 2025 * |
1.68% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 31/12/08 |
Director of Finance/CFO | 52 | 05/09/21 | |
Chief Tech/Sci/R&D Officer | 48 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 23/09/02 |
Catherine Burzik
BRD | Director/Board Member | 73 | 28/01/13 |
Director/Board Member | 69 | 25/07/10 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.04% | 178B | |
-5.71% | 98.95B | |
-8.71% | 44.11B | |
+7.94% | 43.82B | |
+10.10% | 42.74B | |
+11.17% | 28.92B | |
+18.89% | 25.06B | |
-8.59% | 23.38B | |
-11.59% | 21.93B |
- Stock Market
- Equities
- BDX Stock
- BDXA Stock